Skip to content

Multicenter randomized controlled trial exploring postoperative complications and mobilization following major abdominal surgery with vs. without fitness tracker-based feedback (EXPELLIARMUS) - a CHIR-Net Student-Initiated German Medical Audit trial (CHIR-Net SIGMA trial)

Multicenter randomized controlled trial exploring postoperative complications and mobilization following major abdominal surgery with vs. without fitness tracker-based feedback (EXPELLIARMUS) - a CHIR-Net Student-Initiated German Medical Audit trial (CHIR-Net SIGMA trial) - EXPELLIARMUS

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
DRKS
Registry ID
DRKS00016755
Enrollment
348
Registered
2019-03-06
Start date
2019-06-04
Completion date
Unknown
Last updated
2025-04-07

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Patients undergoing major abdominal surgery

Interventions

Group 1: Patients are fitted with a wearable fitness tracker on their wrist for the duration of their postoperative stay until discharge or a maximum of 30 days. Patients receive real-time visual feed

Sponsors

Universitätsklinikum Ulm
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to No maximum

Inclusion criteria

Inclusion criteria: Preoperative inclusion criteria: 1. Patients scheduled for elective major abdominal surgery defined as procedures expected to last more than 2 hours, or with an anticipated blood loss greater than 500 ml 2. Ability to understand the character and individual consequences of the clinical trial 3. Open or laparoscopic or robotic surgery or any variant (laparoscopic-assisted, hybrid procedures etc.) 4. Written informed consent 5. Age =18 years Intra-/postoperative inclusion criteria: 1. Expected postoperative stay on the intensive care or intermediate care ward is less than 4 days. 2. No planned reoperation within 30 days 3. Confirmed major abdominal surgery (=defined as procedures expected to last more than 2 hours, or with an anticipated blood loss greater than 500 ml.

Exclusion criteria

Exclusion criteria: 1. American Society of Anesthesiologists (ASA) grade >3 2. Preoperative immobility or inability to walk unaided 3. Participation in another interventional trial with interference of intervention and outcome of this study 4. Expected postoperative stay on the intensive care or intermediate care ward >= 4 days 5. Planned reoperation within 30 days after index operation 6. Planned abdominal-thoracic operations (two-field surgeries)

Design outcomes

Primary

MeasureTime frame
Postoperative complications measured via the comprehensive complication index (CCI) within 30 days after the index operation.

Secondary

MeasureTime frame
1. Number of steps until POD 8 or until discharge. 2. QoR-15 at baseline and on POD 4 (or at discharge) 3. Activity data until discharge or a maximum of 30 days. 4. Health-related quality of life measured via the EORTC QLQ-C30 at baseline, on POD 8 (or discharge, whatever comes first) and on postoperative day 30 5. 6-minute walking test at POD 6 (or discharge, whatever comes first) 6. Time until return of bowel function measured via the GI-2 score 7. Postoperative pulmonary complications according to the Melbourne group score during hospital stay 8. Deep vein thrombosis until POD 30 9. Pulmonary embolism until POD 30 10. Time from day of index surgery to achieve uninterrupted ambulation greater than 10 min. 11. 30-day mortality 12. Length of hospital stay 13. Discharge destination from the acute hospital ward 14. Pain via the numeric rating scale on POD 2,4,6 at rest and during movement 15. Postoperative unintended falls/collapses until day of discharge

Countries

Germany

Contacts

Public ContactAndré Mihaljevic

Klinik für Allgemein- und ViszeralchirurgieUniversitätsklinikum Ulm

andre.mihaljevic@uniklinik-ulm.de0731-50053502

Outcome results

None listed

Source: DRKS (via WHO ICTRP) · Data processed: Feb 28, 2026